Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation

NCT: NCT05556460 · RECRUITING

NCT IDNCT05556460
StatusRECRUITING
Start Date2024-09-03
Completion2032-08-15
SponsorHangzhou Valgen Medtech Co., Ltd (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of this trial is to demonstrate the safety and effectiveness of the DragonFly-T system in improving clinical outcomes in symptomatic patients with severe tricuspid regurgitation (TR), who are at intermediate or greater estimated risk for mortality or morbidity with tricuspid valve surgery. This randomized controlled trial will compare the investigational device (DragonFly-T system) to Control (Medical Therapy).

Frequently Asked Questions

What is Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation?

Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation is a clinical trial registered under NCT05556460. Current status: RECRUITING.

What is the status of NCT05556460?

The current status of NCT05556460 (Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation) is: RECRUITING.

When did Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation start?

Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation started on 2024-09-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.